FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1466-1467 April 1, 2004 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Attal, M. PubMed Citation

To the Editor: Attal et al. (Dec. 25 issue)¹ report that double autologous stem-cell transplantation improves overall survival among patients with multiple myeloma, especially those who do not have a very good partial response after a first transplantation. However, these results are potentially misleading, for several reasons: the intention-to-treat analysis showed no difference in overall survival between the two groups; the study end point was not the survival rate, but the rate of complete response; the intervals between the diagnosis and the first transplantation and between the first and second transplantations varied; the different conditioning regimen used after the first . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.